Click here to create your personal news page. The news that appears on Eli Lilly will appear there and be constantly updated. You can then modify the page, share it with your friends, or export it and have it appear elsewhere.

You can also create a personal news page and follow the news that interests you by clicking on the tab labelled 'New page'.
 

topics : related - allExplore

Wikio Shopping (beta)

  1. 1. Computers
  2. 2. Electronics
  3. 3. Communication
  4. 4. Household Appliances
  5. 5. Car/Motor Bike
  6. 6. Digital Camera
  7. 7. Mobile Phone
  8. 8. Smartphone
  9. 9. PDA
  10. 10. GPS
  11. 11. LCD Monitor
  12. 12. Printer

New products

  1. 1. Sony KLV-40ZX1M
  2. 2. Lexmark X7675
  3. 3. Lexmark X4975ve
  4. 4. MSI Wind U100-1618XP
  5. 5. JVC DLA-HD750
  6. 6. Epson PowerLite Home Cinema 6100
  7. 7. Toshiba Gigaframe L80
  8. go to Shopping

Participate



Eli Lilly


Sort by : relevance - date - popularity
+Vote!

Did Eli Lilly Downplay Zyprexa’s Health Risks?

A New York City federal judge ordered drug company Eli Lilly to unseal confidential documents concerning the popular antipsychotic drug Zyprexa (Olanzapine) this past Friday, after a lengthy legal dispute. Yesterday’s New York Times reports: The decision by Judge Jack B. Weinstein of Federal District Court came as part of a ruling that gave class-action status [...]

+Vote!

Eli Lilly's Brewing Battle With Bristol-Myers

Mike Huckman submits: Last week I blogged about Eli Lilly's (LLY) "Coming Soon" banner ad I spotted in the online edition of The New England Journal of Medicine . It's designed to generate buzz about the company's crucial new bloodthinner that could win Food and Drug Administration approval this month. Effient would compete with Bristol-Myers Squibb's (BMY) top-selling drug in that category, Plavix....

+Vote!

Judge to Unseal Documents on the Eli Lilly Drug Zyprexa

The New York Times reports that a federal judge in Brooklyn decided on Friday to unseal confidential materials about Eli Lilly's top-selling antipsychotic drug Zyprexa, citing “the health of hundreds of thousands of people” and “fundamental questions” about the way...

+Vote!

4 More Deaths Reported Among Byetta Patients (HealthDay)

TUESDAY, Aug. 26 (HealthDay News) -- The makers of the type 2 diabetes drug Byetta reported Tuesday the deaths of four more mob who'd been pleasing the medication. The announcement by Eli Lilly and Amylin Pharmaceuticals Inc. came a week after the U.S. Food and Drug Administration said that two Byetta users had died of acute pancreatitis, a condition that be possible to cause nausea, vomiting and...

+Vote!

Bush's AIDS Czar and the DC Madam

Excerpt from: "Relief Disaster," by Joshua Kurlantzick, Mother Jones , September/October 2008 Issue: ... To run his AIDS initiative, Bush tapped former Eli Lilly CEO Randall Tobias, who turned out to be oblivious to his own staff's on-the-ground experience. "We'd be at meetings, go around the table, and someone would mention, 'I've just been in Ghana,' and Tobias would say, 'Yes, next,'" the USAID...

12Vote!

FDA lists 20 drugs under scrutiny

Medications cited for potential safety problems Eli Lilly & Co.'s antidepressant Cymbalta and AstraZeneca PLC's antipsychotic Seroquel are among 20 drugs cited by U.S. regulators in their first quarterly list of medicines under investigation for potential safety problems.

+Vote!

Eli Lilly Japan Seeking New Uses For Existing Drugs

Eli Lilly Japan Seeking New Uses For Existing DrugsTOKYO (Nikkei)--The local arm of U.S. drug firm Eli Lilly & Co. is working to expand sales in Japan by broadening the applications of its existing drugs.

+Vote!

Eli Lilly Once Again Goes After Alaska Lawyer Over Zyprexa Documents

As I noted a few weeks ago, the Bloomberg wire service fought to get some documents unsealed in the Alaska v. Lilly lawsuit, settled earlier this year, over allegations that the company's antipsychotic Zyprexa had serious problems and that the...

+Vote!

Baker & Daniels cited for diversity policies

INDIANAPOLIS » Baker & Daniels was the only Indiana law firm to get the top rating of 100 percent on a "corporate equality index" by the Human Rights Campaign Foundation. The index measures a company's treatment of gay, lesbian, bisexual and transgender employees and consumers. Drug maker Eli Lilly and Co.

+Vote!

Idaho presses case against best-selling medication -Boise (ID) Statesman

By Colleen LaMay - clamay@idahostatesman.com Idaho has joined a parade of states suing Eli Lilly over the pharmaceutical company's top-selling drug, an antipsychotic medicine called Zyprexa. Idaho says Zyprexa is a costly drug that has been improperly marketed, sickening Idaho patients and taking a financial bite from the state's Medicaid health insurance program for low-income and disabled

+Vote!

Amylin Pharmaceuticals And Eli Lilly Provide Context For FDA Alert For BYETTA

Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) in a conference call today provided context and additional information regarding the August 18, 2008 U.S. Food and Drug Administration (FDA) update to a prior alert for BYETTA(R) (exenatide) injection referencing pancreatitis.

2Vote!

Two More Deaths Reported From Diabetes Drug Users

The makers of the type 2 diabetes drug Byetta reported deaths of four more people who'd been taking the medication, bringing the total to six. Last week, Eli Lilly & Co. and Amylin Pharmaceuticals Inc.'s diabetes drug Byetta has previously been linked to two deaths and four hospitalizations. All the patients are reported to have died after developing acute pancreatitis, the manufacturer said. The condition...

+Vote!

Diabetes Drug Tied to New Deaths

The New York Times reports that four more deaths may be linked to the diabetes drug Byetta. The New York Times writes, The diabetes drug Byetta, marketed by Eli Lilly & Company and Amylin Pharmaceuticals, was linked to four more...

+Vote!

Baneful Byetta

Four new deaths stemmed from Amylin and Eli Lilly's diabetes drug, which sent investors running.

+Vote!

Bad News Byetta

Amylin Pharmaceuticals and Eli Lilly announce four new deaths among patients taking the diabetes drug.